Council Regulation (EC) No 1110/1999 of 10 May 1999 providing for duty-free treatment of specified pharmaceutical active ingredients bearing an international non-proprietary name (INN) from the World Health Organisation and specified products used for the manufacture of finished pharmaceutical products

• CELEX: Regulation (EC) No 1110/1999
• Articles: 5

Article 1

As from 1 July 1999 the Community shall accord duty-free treatment for the INNs listed in Annex I as well as the salts, esters and hydrates of such products.

Article 2

As from 1 July 1999 the Community shall accord duty-free treatment for the products used in the production and manufacture of finished pharmaceutical products listed in Annex II.

Article 3

As from 1 July 1999 the specified prefixes and suffixes of INNs eligible for duty-free treatment shall include those listed in Annex III.

Article 4

This Regulation shall enter into force on the seventh day following that of its publication in the Official Journal of the European Communities.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 10 May 1999.

For the Council

The President

H. EICHEL

Schedules & Appendices

ANNEX I

Additional INNs to receive duty-free treatment

>TABLE>

ANNEX II

Additional pharmaceutical intermediates, namely compounds used for the manufacture of finished pharmaceutical products, to receive duty-free treatment

>TABLE>

ANNEX III

Additions to the list of prefixes and suffixes which, in combination with the INNs, describe salts, esters or hydrates of INNs

Benzoate

Difumarate

Dipivoxil

Monobenzoate

Tetraisopropyl